ImmunoMind Company
Multi-Omics Driven Development of Effective Cell Therapies
Technology:
Artificial Intelligence, Biotechnology, Genetics
Industry:
End-to-end Drug Development, United States
Headquarters:
Berkeley, California, United States
Founded Date:
2020-01-01
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
1
Total Funding:
755000
Last Funding Date:
2022-01-01
Last Funding Type:
Pre-Seed
Register and Claim Ownership